GMO says QE2 set to hit shoals

On the eve of an anticipated second round of quantitative easing – QE2 – a number of commentators, including GMO’s Jeremy Grantham, have criticised Fed’s policy as a large net negative to the production of a healthy, stable economy.

According to Grantham, chief investment strategist and co-founder of GMO, in almost every respect, adhering to a policy of low rates, employing quantitative easing, deliberately stimulating asset prices, ignoring the consequences of bubbles breaking, and displaying a complete refusal to learn from experience has left Fed policy as a large net negative to the production of a healthy, stable economy with strong employment.

He believes that there is likely to be no benefit to artificially low rates, and more so, quantitative easing is likely to turn out to be an even more desperate move than the typical low rate policy. Importantly, by increasing inflation fears, this easing has sent the dollar down and commodity prices up, he says in his quarterly letter.

Weakening the dollar and being seen as certain to do that increases the chances of currency friction, which could spiral out of control.

“If I were a benevolent dictator, I would strip the Fed of its obligation to worry about the economy and ask it to limit its meddling to attempting to manage inflation.

Sponsored Content

“Better yet, I would limit its activities to making sure that the economy had a suitable amount of liquidity to function normally.

“Further, I would force it to swear off manipulating asset prices through artificially low rates and asymmetric promises of help in tough times – the Greenspan/Bernanke put.

It would be a better, simpler, and less dangerous world, although one much less exciting for us students of bubbles. Only by hammering away at its giant past mistakes as well as its dangerous current policy can we hope to generate enough awareness by 2014: Bernanke’s next scheduled reappointment hearing.”

In recommendations, Grantham says investors should:

Emphasise US quality companies, which are still cheap in an overpriced world

Moderately overweight emerging market equities

Moderately underweight the balance of global equities

Heavily underweight lower quality US companies

Carry extra cash reserves for a volatile market with insecure fundamentals

For the very long term (20 years) overweight resources, particularly if they have a sharp decline (this is Grantham’s personal view rather than that of GMO, which on this topic is agnostic).

Leave a Comment

Sort content by

Good ESG data requires a framework

Initiatives such as the Sustainability Accounting Standards Board are vital for providing the consistent, regular, high-quality disclosure on the SDGs that investors need, a panel told delegates.

Irish pensions headed for major reforms

Auto-enrolment will put more people into Ireland's public retirement system, while regulatory requirements will include tougher standards for trustees and more disclosure on ESG.

Funds team up on G7 priorities

A group of institutional investors are collaborating to address the G7 priorities of climate change, gender inequality and the infrastructure gap, agreeing to commit resources and expertise.

Trustees answer the tenure question

The Australian Prudential Regulation Authority has given guidance for how long trustees should sit on boards. How well does the theory suit the practice? Stakeholders weigh in.

Whineray takes the reins at NZ Super

New Zealand Super acting chief executive Matt Whineray was named to the position permanently on Tuesday. He replaces long-time fund CEO Adrian Orr and vacates his chief investment officer role.

MSCI leaves out suspended A-shares

A handful of companies halted trading this week, prompting MSCI to drop plans to add them to its emerging markets index as it made the long-awaited inclusion of 229 China-listed stocks.

Previous